한글목차

전립선암, 유방암, 폐암, 대장암, 자궁경부암의 각 시장에서의 기회로 인해 세계 방사선 치료 시장의 미래는 유망합니다. 세계 방사선 치료 시장은 2025년부터 2031년까지 5.9%의 연평균 복합 성장률(CAGR)로 2031년 약 113억 달러에 달할 것으로 예상됩니다. 이 시장의 주요 촉진요인은 암 발병률 증가, 방사선 치료 기술의 발전, 노인 인구 증가입니다.

• Lucintel의 예측에 따르면, 유형별로는 외부 방사선 치료가 예측 기간 동안 가장 큰 부문을 차지할 것으로 보입니다. 이는 암세포에 직접 조사하는 정확도가 높아 정상 조직에 대한 손상이 적고, 종양 전문의가 고선량의 방사선 요법을 사용할 수 있기 때문입니다.
• 용도별로는 전립선암의 발병률이 증가하고 있고, 다른 암종에 비해 성공률이 높기 때문에 전립선암이 가장 큰 부문을 차지할 것으로 예상됩니다.
• 지역별로는 아시아태평양이 방사선 치료에 대한 인식 증가, 의료비 지출 증가, 노인 인구 증가로 인해 예측 기간 동안 가장 높은 성장세를 보일 것으로 예상됩니다.

방사선 치료 시장의 전략적 성장 기회

새로운 용도와 기술이 등장하고 치료의 폭과 깊이가 증가함에 따라 방사선 치료 시장은 향후 몇 년동안 큰 성장 잠재력을 가지고 있습니다. 보다 정밀한 치료법이 필요한 암 발병률 증가와 함께 다양한 응용 분야에서 전략적 성장 기회를 창출하고 있습니다.

• 양성자 치료 센터의 확장: 양성자 치료 센터의 확장은 방사선 치료 산업에서 매력적인 성장 기회입니다. 적은 부작용과 높은 표적 정확도 등 양성자 치료의 장점이 알려지면서 양성자 치료에 대한 수요가 증가하고 있습니다. 새로운 양성자 치료 센터가 전 세계적으로 설립되고 있으며, 특히 미국과 같이 첨단 암 치료가 제한되어 있는 국가들에서 설립되고 있습니다. 따라서 방사선 치료 시장의 성장은 양성자 치료의 이용 확대에 의해 견인될 것으로 예상되며, 더 많은 사람들이 이용할 수 있도록 가격이 저렴해져 수용이 촉진될 것으로 예상됩니다.
• 개인 맞춤형 치료를 위한 AI 활용의 성장: 임상 방사선 치료 계획에 AI를 활용하는 것에 대한 시장의 관심이 높아지고 있으며, AI는 다양한 변수를 평가할 수 있어 효능을 극대화하고 부작용을 최소화하는 개인 맞춤형 치료법을 만들 수 있습니다. 치료 효과와 환자 치료의 질적 향상을 기대할 수 있습니다. 이러한 추세는 방사선 치료 시장의 미래에 중심적인 역할을 할 것으로 보이는 새로운 AI 기반 제품 및 소프트웨어의 성장을 가속하고 있습니다.
• 저분할 방사선 치료의 확대: 임상의와 환자가 더 나은 더 빠른 치료법을 요구함에 따라 저분할 방사선 치료의 사용은 계속 확대되고 있습니다. 저분할 방사선 치료는 단기간에 치료가 이루어지기 때문에 의료 시스템의 부담을 줄이고 환자 경험을 향상시킵니다. 이는 특히 단시간에 고선량의 방사선을 조사하는 암 치료에 유리합니다.

저분할 방사선 치료의 도입이 진행됨에 따라, 특히 다양한 건강 문제를 가진 사람들에게 저비용으로 번거로움이 적은 치료법이라는 점에서 시장 확대가 예상됩니다.

• 신흥 시장에서의 방사선 치료 확대: 신흥 시장은 방사선 치료 서비스 성장에 큰 기회가 될 수 있습니다. 이들 지역은 의료 인프라가 잘 갖추어져 있고, 방사선 치료를 포함한 첨단 암 치료에 대한 수요가 증가하고 있습니다. 신흥 시장의 정부 및 민간 의료 부문은 방사선 치료 센터 건설과 최신 기술 도입에 많은 투자를 하고 있습니다. 이러한 확대는 전 세계적으로 더 많은 환자들에게 첨단 암 치료를 제공함으로써 방사선 치료 시장을 뒷받침할 것으로 기대됩니다. 이러한 신흥국 시장의 발전이 지속됨에 따라 방사선 치료 시장 전체의 성장과 발전에 중요한 역할을 할 것으로 예상됩니다.

방사선 치료 시장의 전략적 성장 기회는 양성자 치료 센터의 신설, 개인 맞춤형 치료에 인공지능의 통합, 저분할 방사선 치료의 확대, 신흥 경제국에서의 성장, 암 치료를 크게 개선하기 위한 면역 요법과의 연계 등을 통해 제공되고 있습니다. 이러한 기회를 노리는 전략은 단순히 방사선 치료의 범위를 넓히는 것뿐만 아니라, 그 효과를 높이고 환자 결과를 개선하고 있습니다. 이러한 변화는 가까운 미래에 발전할 것으로 예상되며, 더 많은 환자들에게 개인화된 암 관리 요법을 보다 효율적으로 제공하기 위해 방사선 치료 시장의 성장에 영향을 미칠 것으로 보입니다.

방사선 치료 시장 성장 촉진요인 및 과제

방사선 치료 시장은 기술 개발, 경제 요인, 규제의 상호 작용에 의해 형성되고 있습니다. 이러한 측면은 기술 혁신과 시장 확대에 박차를 가하는 동시에 정체를 피하기 위해 해결해야 할 중요한 과제를 제시하고 있습니다. 주요 촉진요인으로는 암 환자 증가, 방사선 치료 기술 향상, 의료비 지원, 방사선 치료에 대한 인식 증가, 정부의 암 치료 강화 프로그램 등을 들 수 있습니다.

방사선 치료 시장의 성장을 가속하는 요인은 다음과 같습니다:

• 암 발병률 증가: 암 발병률 증가: 전 세계 암 환자 증가는 방사선 치료 시장의 중요한 촉진요인입니다. 고령화와 생활습관이 암 위험의 한 요인으로 작용하면서 효과적인 치료 옵션에 대한 수요가 증가하고 있습니다. 라이프스타일의 변화, 인구 고령화, 환경적 영향 등 다양한 요인으로 인해 암 환자가 증가함에 따라 방사선 치료의 필요성이 대두되고 있습니다.
• 기술 발전: 양성자 치료, MR-리니어릭 시스템, AI 통합 개발 등 방사선 기술의 급속한 발전으로 방사선 치료의 효과와 효율성이 향상되고 있습니다. 이러한 기술은 치료를 보다 안전하고 정확하게 만들고, 더 많은 환자들이 쉽게 이용할 수 있도록 돕고 있습니다.
• 정부 이니셔티브 및 자금 지원: 각국 정부는 암 치료 인프라 구축 및 방사선 치료 접근성 확대를 위한 헬스케어 이니셔티브에 대한 투자를 늘리고 있습니다. 이러한 이니셔티브는 인지도를 높이고 이용 가능한 치료 센터를 증가시킴으로써 시장 성장에 크게 기여하고 있습니다.
• 환자의 인식과 수용: 암 치료와 방사선 치료의 이점에 대한 인식이 높아짐에 따라 더 많은 환자들이 치료를 받고 있습니다. 이러한 인식의 변화는 시장 수요에 긍정적인 영향을 미치고 있습니다.

방사선 치료 시장의 성장을 저해하는 요인은 다음과 같다:

• 장비 및 치료 비용 상승: 첨단 방사선 치료 장비의 초기 설정에 많은 비용이 들기 때문에 일부 의료 시설, 특히 신흥 시장에서는 새로운 기술을 도입하는 데 어려움이 있을 수 있습니다. 이러한 높은 비용으로 인해 최신 방사선 치료 옵션에 대한 접근성이 제한될 수 있습니다.
• 숙련된 전문가 부족: 자격을 갖춘 방사선 종양 전문의, 의학 물리학자 및 기타 숙련된 인력의 부족은 첨단 방사선 치료 기술의 효과적인 시행을 방해할 수 있습니다. 이러한 격차는 환자의 치료 접근을 지연시키고 치료 결과에 영향을 미칠 수 있습니다.
• 규제 과제: 방사선 치료 산업은 국가마다 다른 복잡한 규제 상황을 극복해야 합니다. 엄격한 규제에 대한 대응은 제품 출시 지연과 신기술 도입에 따른 비용 증가로 이어질 수 있습니다.
• 환자별 요인: 환자 개개인의 건강 상태와 유전적 소인은 치료 결과에 영향을 미칠 수 있습니다. 이러한 요인을 이해하는 것은 방사선 치료의 개별화에 필수적이지만, 치료 프로토콜에서 이러한 요인을 적절히 다루는 것은 여전히 과제로 남아있습니다.

결론적으로, 방사선 치료 시장은 몇 가지 성장 요인에 의해 주도되고 있지만, 동시에 큰 문제에 직면해 있습니다. 이러한 요소들의 균형을 맞추는 것이 이 분야를 발전시키고 환자가 가장 효과적이고 접근하기 쉬운 치료를 받을 수 있도록 하는 데 중요합니다.

목차

제1장 주요 요약

제2장 세계의 방사선 치료 시장 : 시장 역학

• 서론, 배경, 분류
• 공급망
• 업계 촉진요인과 과제

제3장 시장 동향과 예측 분석(2019-2031년)

• 거시경제 동향(2019-2024년)과 예측(2025-2031년)
• 세계의 방사선 치료 시장 동향(2019-2024년)과 예측(2025-2031년)
• 세계의 방사선 치료 시장 : 유형별
  • 외부 방사선 치료
  • 내부 방사선 치료
  • 전신 방사선 요법
• 세계의 방사선 치료 시장 : 용도별
  • 전립선암
  • 유방암
  • 폐암
  • 대장암
  • 자궁경부암
  • 기타
• 세계의 방사선 치료 시장 : 최종 용도별
  • 병원
  • 독립 방사선 치료센터
  • 기타

제4장 시장 동향과 예측 분석 : 지역별(2019-2031년)

• 세계의 방사선 치료 시장 : 지역별
• 북미의 방사선 치료 시장
• 유럽의 방사선 치료 시장
• 아시아태평양의 방사선 치료 시장
• 기타 지역의 방사선 치료 시장

제5장 경쟁 분석

• 제품 포트폴리오 분석
• 업무 통합
• Porter의 Five Forces 분석

제6장 성장 기회와 전략 분석

• 성장 기회 분석
  • 세계의 방사선 치료 시장 성장 기회 : 유형별
  • 세계의 방사선 치료 시장 성장 기회 : 용도별
  • 세계의 방사선 치료 시장 성장 기회 : 최종 용도별
  • 세계의 방사선 치료 시장 성장 기회 : 지역별
• 세계의 방사선 치료 시장의 새로운 동향
• 전략 분석
  • 신제품 개발
  • 세계의 방사선 치료 시장 능력 확대
  • 세계 방사선 치료 시장에서의 인수합병(M&A) 및 합작투자(JV)
  • 인증 및 라이선싱

제7장 주요 기업 개요

• Ion Beam Applications
• Elekta
• Accuray Incorporated
• Isoray
• Becton
• Dickinson and Company
• Siemens Healthineers
• ICAD
• Nordion
• MEVION MEDICAL SYSTEMS

영문목차

The future of the global radiotherapy market looks promising with opportunities in the prostate cancer, breast cancer, lung cancer, colorectal cancer, and cervical cancer markets. The global radiotherapy market is expected to reach an estimated $11.3 billion by 2031 with a CAGR of 5.9% from 2025 to 2031. The major drivers for this market are the increasing cancer incidence, advancements in radiotherapy technology, and the growing geriatric population.

• Lucintel forecasts that, within the type category, external beam radiation therapy will remain the largest segment over the forecast period due to the accuracy of the direct beams at the cancerous cells, which results in less damage to normal tissues, while allowing oncologists to use higher doses of radiotherapy for treatment.
• Within the application category, prostate cancer will remain the largest segment due to the growing incidence of prostate cancer and higher success rate as compared to other cancer types.
• In terms of regions, APAC is expected to witness the highest growth over the forecast period due to the growing awareness about radiotherapy, rising healthcare expenditure, and increasing geriatric population in the region.

Gain valuable insights for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Radiotherapy Market

The phenomenon and trends prevailing in the radiotherapy market are changing for the better due to technological advancements, changing healthcare needs, and the search for more efficient ways to treat cancer. New developments in this area, expanding beyond the limited view of seeking only cancer cures, are improving not only the effectiveness of radiotherapy but also reinforcing its use in a greater variety of cancers and for more patients. As healthcare institutions and practitioners remain innovative, it is safe to say that these trends will transform the cancer care sector for the better by providing more treatment options and offering greater hope to patients.

• Proton Therapy Expansion: Proton therapy is emerging as one of the leading approaches in the treatment of specific tumor types, especially those located close to critical organs such as the brain and spinal cord. This trend stems from the fact that high doses of radiation can be delivered within a shorter distance from the tumor while inflicting less or no damage to normal tissue. Several proton therapy facilities are being established globally, thereby increasing the accessibility of advanced treatment to a growing pool of patients. More facilities and manpower are expected to be developed for the administration of proton therapy, further diversifying the radiotherapy industry and improving outcomes.
• Integration of Artificial Intelligence (AI): Artificial intelligence is changing the landscape of the radiotherapy market by increasing the precision and speed of treatment planning and delivery. Complex images are analyzed, the optimal radiation dose is determined, and the outcomes for each patient are predicted as accurately as possible, thanks to specially developed AI algorithms. This approach is also helping to shorten the treatment planning phase, reducing the waiting period for patients before treatment commences. Improvements in AI will enhance integration in radiotherapy, with expectations for greater precision in treatments, fewer adverse effects, and better results for patients.
• Increasing Use of Image-Guided Radiotherapy (IGRT): Recently, there has been a significant advent of new technology in Image-Guided Radiotherapy (IGRT). IGRT includes the availability of live images, such as Computed Tomography (CT) or MRI-guided tumor volume imaging, during radiotherapy delivery. This allows for adjustments during treatment to accommodate tumor movements or patient repositioning. The increasing use of IGRT is enhancing treatment accuracy, lowering unintended radiation doses to patients, and improving the prospects of radiation therapy for more types of cancer.
• Combination of Radiotherapy with Immunotherapy: Integrating radiotherapy with immunotherapy is a new trend that has high potential and will improve outcomes in cancer treatment. Immunotherapy enhances the body's immune response to detect and address cancerous tissues, complementing radiotherapy that involves radiation exposure. This combination treatment strategy is effective for cancers that do not respond to conventional treatment approaches. Research is ongoing, and clinical trials are underway to establish the best combinations and sequences of such treatments to ensure their maximal effect and broaden their clinical applications.

Newly developed concepts within the radiotherapy market, such as management of proton therapy by centers, incorporation of AI, the rise in application of IGRT, combination with immunotherapy, and individualization of treatment, stand to change the narrative around cancer treatment. These improvements are not just augmenting the accuracy and efficacy of radiotherapy techniques; they are also expanding the scope of radiotherapy usage for more patients with various oncological diseases. As these trends advance, they are poised to propel the growth of the radiotherapy market and improve the prognosis for patients diagnosed with cancer worldwide.

Recent Developments in the Radiotherapy Market

The radiotherapy market is inundated with new technologies, approved regulations, and increasing investment interest due to cancer treatments. All these developments aim to enhance the quality of radiotherapy treatments and improve patient outcomes. As the demand for advanced cancer therapies increases, the thermotherapy market is expanding, showcasing advanced techniques and equipment to develop individualized therapies targeting specific ailments.

• Advancement in Proton Therapy: Proton therapy has developed significantly and has emerged as a breakthrough in the radiotherapy market, as it offers better chances of targeting tumor regions without harming healthy tissues. Recently, efforts have focused on making proton therapy more viable and addressing existing limitations in the number of centers offering this therapy due to high costs. These trends encourage the use of proton therapy for many more malignancies, even those currently treated solely with surgical methods or those resistant to conventional radiotherapy. The rise in the availability of proton therapy services is anticipated to have substantial potential in the radiotherapy market by reaching more patients.
• Integration of Artificial Intelligence in Treatment Planning: The use of artificial intelligence (AI) in the planning of radiotherapy treatments is changing the market for the better by increasing the efficiency and accuracy of treatment protocols. Recently, AI is being applied to manage patient information, optimize radiation doses, and predict outcomes. This evolution not only shortens the duration of treatment planning but also facilitates greater individualization in treatment approaches. Continued advancements in AI will further enhance its effectiveness in radiotherapy, contributing to market growth.
• Expansion of Stereotactic Body Radiotherapy (SBRT): Stereotactic Body Radiotherapy (SBRT) is quickly becoming the conventional option for managing specific types of cancer, particularly carcinomas of the lung, liver, and spine. Delivery of SBRT typically occurs in three to five treatment sessions rather than the numerous fractions traditionally offered, resulting in fewer complications compared to surgical approaches. The last decade has focused on improving SBRT modalities, refining patient selection, and broadening its application for additional oncological indications. Given the clinically satisfactory results achieved, the market for these systems is expected to grow as more patients seek effective yet less harmful treatment through SBRT.
• Development of MR-Linac Technology: The advancement of Magnetic Resonance Linear Accelerator (MR-Linac) technology represents a revolutionary advance in radiation oncology. MR-Linac allows for tumor visualization while directing radiation, leveraging the benefits of MRI and the linear accelerator. This technology enhances radiation delivery to the tumor and allows for adjustments based on tumor movement, making treatment more effective and minimizing side effects. The emergence of MR-Linac technology improves the effectiveness of radiotherapy for complex and mobile tumors, thus positively contributing to the growth of the radiotherapy market.

Recent trends in the radiotherapy market, such as the advent of proton therapy, incorporation of artificial intelligence, expansion of SBRT, MR-Linac technology, and hypofractionated radiotherapy, are transforming cancer treatment. These developments are not only increasing the accuracy and efficacy of radiotherapy but also enhancing the affordability and convenience of this treatment.

Strategic Growth Opportunities for Radiotherapy Market

There is substantial growth potential in the radiotherapy market in the coming years as new applications and technologies emerge, enhancing the breadth and depth of therapies. Strategic growth opportunities are arising in different applications due to the rising incidence of cancer requiring advanced treatment alongside more targeted approaches.

• Expansion of Proton Therapy Centers: The expansion of proton therapy centers presents an attractive growth opportunity in the radiotherapy industry. Demand for such therapy is increasing as the advantages of proton therapy, such as lower side effects and higher targeting precision, become more recognized. New proton therapy centers are being established worldwide, especially in countries where advanced cancer treatments are limited, such as in the US. Therefore, it is predicted that the growth of the radiotherapy market will be driven by increased proton therapy usage, making it affordable to a larger population and encouraging its acceptance.
• Growth in the Use of AI for Personalized Treatment: There is growing market interest in utilizing AI for clinical radiation therapy planning. AI can evaluate many variables, allowing for the creation of individualized therapies that maximize efficacy and minimize adverse effects. Continued developments in AI will lead to broader applications in radiotherapy, further improving the effectiveness of procedures and patient care. This trend is fueling the growth of new AI-based products and software that are likely to play a central role in the future of the radiotherapy market.
• Expansion of Hypofractionated Radiotherapy: The use of hypofractionated radiotherapy continues to grow as clinicians and patients seek better and faster treatment methods. Hypofractionation involves delivering treatment over a shorter period, easing the burden on the healthcare system and improving patient experience. This is particularly favorable for treating cancers with shorter, higher radiation doses.

With the increasing adoption of hypofractionated radiotherapy, market expansion is anticipated, as this is a low-cost and less cumbersome treatment option, especially for populations with diverse health concerns.

• Radiotherapy Expansion in Emerging Markets: Emerging markets offer significant opportunities for the growth of radiotherapy services. With improvements in healthcare infrastructure in these regions, the demand for advanced cancer therapies, including radiotherapy, is rising. Governments and private health sectors in emerging markets are investing heavily in building radiotherapy centers and deploying modern technology. This escalation is expected to support the radiotherapy market by providing advanced cancer treatment to more patients than ever before on a global scale. As these markets continue to develop, they are likely to play a vital role in the overall growth and development of the radiotherapy market.

Strategic growth opportunities in the radiotherapy market are being driven by the establishment of new proton therapy centers, the integration of artificial intelligence in personalized treatment, the expansion of hypofractionated radiotherapy, growth in developing economies, and collaboration with immunotherapy to significantly improve cancer treatment. Strategies targeting these opportunities are not just widening the scope of radiotherapy; they are also enhancing its efficacy and improving patient outcomes. These changes are anticipated to develop in the near future and will influence the growth of the radiotherapy market toward delivering personalized cancer management therapies efficiently to more patients.

Radiotherapy Market Driver and Challenges

The radiotherapy market is shaped by the interplay between technological development, economic factors, and regulations. These aspects spur innovation and market expansion while also presenting significant challenges that need to be addressed to avoid stagnation. Key drivers include the rise in cancer cases, technological improvements in radiation therapy, support for healthcare costs, increased awareness of radiotherapy treatments, and government cancer treatment enhancement programs.

The factors responsible for driving the growth of the radiotherapy market are:

• Rising Cancer Incidence: The global increase in cancer cases is a significant driver of the radiotherapy market. With an aging population and lifestyle factors contributing to cancer risk, the demand for effective treatment options is escalating. As cancer cases rise due to various factors like lifestyle changes, population aging, and environmental influences, the need for radiotherapy becomes more pronounced.
• Technological Advancements: Rapid advancements in radiation technology, such as the development of proton therapy, MR-Linac systems, and AI integration, are enhancing the effectiveness and efficiency of radiotherapy. These technologies are making treatments safer, more accurate, and accessible to a broader patient population.
• Government Initiatives and Funding: Governments are increasingly investing in healthcare initiatives aimed at improving cancer treatment infrastructure and expanding access to radiotherapy. These initiatives contribute significantly to market growth by enhancing awareness and increasing the number of available treatment centers.
• Patient Awareness and Acceptance: The growing awareness of cancer treatments and the benefits of radiotherapy is encouraging more patients to seek treatment. This shift in perception is positively influencing market demand.

However, the radiotherapy market faces challenges that may impede growth, including:

• High Costs of Equipment and Treatment: The initial setup costs for advanced radiotherapy equipment are substantial, making it difficult for some healthcare facilities, especially in emerging markets, to adopt new technologies. This high expense can limit access to modern radiotherapy options.
• Shortage of Trained Professionals: A shortage of qualified radiation oncologists, medical physicists, and other trained personnel may hinder the effective implementation of advanced radiotherapy techniques. This gap can delay patient access to treatment and affect outcomes.
• Regulatory Challenges: The radiotherapy industry must navigate complex regulatory landscapes, which can vary by country. Compliance with stringent regulations may lead to delays in product launches and increase the costs associated with new technology adoption.
• Patient-Specific Factors: Individual patient health conditions and genetic predispositions can influence treatment outcomes. Understanding these factors is essential for personalizing radiotherapy, yet challenges remain in adequately addressing them within treatment protocols.

In conclusion, while the radiotherapy market is driven by several growth factors, it also faces significant challenges. Balancing these elements is critical for advancing the field and ensuring patients receive the most effective and accessible treatments possible.

List of Radiotherapy Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies radiotherapy companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the radiotherapy companies profiled in this report include-

• Ion Beam Applications
• Elekta
• Accuray Incorporated
• Isoray
• Becton
• Dickinson and Company
• Siemens Healthineers
• ICAD
• Nordion
• MEVION MEDICAL SYSTEMS

Radiotherapy by Segment

The study includes a forecast for the global radiotherapy market by type, application, end use, and region

Radiotherapy Market by Type [Analysis by Value from 2019 to 2031]:

• External Beam Radiation Therapy
• Internal Radiation Therapy
• Systemic Radiation Therapy

Radiotherapy Market by Application [Analysis by Value from 2019 to 2031]:

• Prostate Cancer
• Breast Cancer
• Lung Cancer
• Colorectal Cancer
• Cervical Cancer
• Others

Radiotherapy Market by End Use [Analysis by Value from 2019 to 2031]:

• Hospitals
• Independent Radiotherapy Centers
• Others

Radiotherapy Market by Region [Analysis by Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Radiotherapy Market

Here's the revised content without single line spaces between sentences, except for headings:

The radiotherapy market is growing at a rapid pace in all parts of the world owing to technological developments, the surge in the number of cancer patients, and the improvement in the status of healthcare services. With the growing recognition of the need for better healthcare, nations are now embracing new methods of radiotherapy and increasing the reach of these services. This growth in demand is additionally attributed to the incorporation of artificial intelligence and precision medicine into the practice of radiotherapy, which increases its effectiveness and safety.

• United States: Among some of the more recent changes in the radiotherapy industry in the United States is the quick adoption of advanced technologies, including proton therapy and SBRT. These modes allow for very precise delivery of radiation to the tumor with minimal damage to the surrounding healthy tissues. Further, the use of artificial intelligence in the treatment planning and delivery mechanisms has boosted the efficiency of radiotherapy, generating commendable results in patients. Finally, the US market is also committing itself to further investments that widen the scope of provision of radiotherapy services, for example, in terms of geography to include rural and clinically underserved regions, in both government and private initiatives.
• China: The radiotherapy market in China is also growing rapidly due to increasing cases of cancer, as well as considerable governmental investments in the healthcare system. Recent developments include improved control of x-ray treatment, where IMRT and IGRT techniques are extensively utilized. Besides, there is considerable activity in the form of building more cancer treatment centers with the best available radiotherapy equipment in China. Collaborations between Chinese institutes and foreign healthcare corporations will also help in the transfer of newer radiotherapy methods and technologies back to China so that it can provide more advanced cancer therapy.
• Germany: * Within the German market of radiotherapy, one has to admit that the country's healthcare is gradually leaning towards models of precision medicine, as well as models that advocate for personalized treatment in generic radiotherapy. Trends such as the growing popularity of using molecular imaging techniques together with radiotherapy to target tumor cells while sparing normal tissues are also underway. Germany is involved in examining strategies that combine radiotherapy with immunotherapy, thereby widening the possibilities for the immune response to tumors. Additionally, the country is working on eliminating geographic barriers for radiotherapy services by increasing the number of specialized centers and adopting state-of-the-art radiotherapy equipment.
• India: There has been significant development in the radiotherapy market in India due to increased awareness, government participation, and public-private partnerships in the cancer treatment sector. This development has led to more complex models evolving in payment structures, which intensify the introduction of advanced radiotherapy methods in cancer hospitals, such as stereotactic radiosurgery (SRS) or brachytherapy. There is also an increased focus on training, education, and orientation of personnel so that professionals can utilize modern radiotherapy technologies. Additionally, there is geographical imbalance in radiotherapy availability. New centers are being created in underserved areas to reduce disparities in cancer treatment across the country.
• Japan: The Japanese radiotherapy market is on an upward trajectory due to the incorporation of newer treatment techniques, including drug delivery using protons and heavy ions for distant and difficult-to-operate tumors. Recent developments also include the use of AI and machine learning in treatment planning, wherein the targeting dose is further improved. Efforts are being made to develop the radiotherapy infrastructure in Japan, with new cancer treatment facilities being built in response to the rising demand for modern cancer treatment services. In addition, there is a greater focus on research and development in the area of radiotherapy, with studies currently being undertaken to combine conventional forms of treatment with others, such as immunotherapy.

Features of the Global Radiotherapy Market

Market Size Estimates: Radiotherapy market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.

Segmentation Analysis: Radiotherapy market size by type, application, and region in terms of value ($B).

Regional Analysis: Radiotherapy Market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the radiotherapy market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the radiotherapy market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the radiotherapy market by type (external beam radiation therapy, internal radiation therapy, and systemic radiation therapy), application (prostate cancer, breast cancer, lung cancer, colorectal cancer, cervical cancer, and others), end use (hospitals, independent radiotherapy centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Radiotherapy Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031

• 3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
• 3.2. Global Radiotherapy Market Trends (2019-2024) and Forecast (2025-2031)
• 3.3: Global Radiotherapy Market by Type
  • 3.3.1: External Beam Radiation Therapy
  • 3.3.2: Internal Radiation Therapy
  • 3.3.3: Systemic Radiation Therapy
• 3.4: Global Radiotherapy Market by Application
  • 3.4.1: Prostate Cancer
  • 3.4.2: Breast Cancer
  • 3.4.3: Lung Cancer
  • 3.4.4: Colorectal Cancer
  • 3.4.5: Cervical Cancer
  • 3.4.6: Others
• 3.5: Global Radiotherapy Market by End Use
  • 3.5.1: Hospitals
  • 3.5.2: Independent Radiotherapy Centers
  • 3.5.3: Others

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

• 4.1: Global Radiotherapy Market by Region
• 4.2: North American Radiotherapy Market
  • 4.2.1: North American Market by Type: External Beam Radiation Therapy, Internal Radiation Therapy, and Systemic Radiation Therapy
  • 4.2.2: North American Market by Application: Prostate Cancer, Breast Cancer, Lung Cancer, Colorectal Cancer, Cervical Cancer, and Others
• 4.3: European Radiotherapy Market
  • 4.3.1: European Market by Type: External Beam Radiation Therapy, Internal Radiation Therapy, and Systemic Radiation Therapy
  • 4.3.2: European Market by Application: Prostate Cancer, Breast Cancer, Lung Cancer, Colorectal Cancer, Cervical Cancer, and Others
• 4.4: APAC Radiotherapy Market
  • 4.4.1: APAC Market by Type: External Beam Radiation Therapy, Internal Radiation Therapy, and Systemic Radiation Therapy
  • 4.4.2: APAC Market by Application: Prostate Cancer, Breast Cancer, Lung Cancer, Colorectal Cancer, Cervical Cancer, and Others
• 4.5: ROW Radiotherapy Market
  • 4.5.1: ROW Market by Type: External Beam Radiation Therapy, Internal Radiation Therapy, and Systemic Radiation Therapy
  • 4.5.2: ROW Market by Application: Prostate Cancer, Breast Cancer, Lung Cancer, Colorectal Cancer, Cervical Cancer, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Radiotherapy Market by Type
  • 6.1.2: Growth Opportunities for the Global Radiotherapy Market by Application
  • 6.1.3: Growth Opportunities for the Global Radiotherapy Market by End Use
  • 6.1.4: Growth Opportunities for the Global Radiotherapy Market by Region
• 6.2: Emerging Trends in the Global Radiotherapy Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Radiotherapy Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Radiotherapy Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Ion Beam Applications
• 7.2: Elekta
• 7.3: Accuray Incorporated
• 7.4: Isoray
• 7.5: Becton
• 7.6: Dickinson and Company
• 7.7: Siemens Healthineers
• 7.8: ICAD
• 7.9: Nordion
• 7.10: MEVION MEDICAL SYSTEMS